Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0.

Savio George BarretoSimone I StrasserGeoffrey W McCaughanMichael A FinkRobert JonesJohn McCallStephen MunnGraeme A MacdonaldPeter HodgkinsonGary P JeffreyBryon JaquesMichael CrawfordMark E Brooke-SmithJohn W Chen

Published in: Cancers (2022)

Overall survival following LT for HCC has significantly improved over time despite expanding criteria from Milan to UCSF. Patients fulfilling the MT2 criteria have a survival comparable to the UCSF cohort. Thus, expansion of criteria to MT2 is justifiable.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
patient reported outcomes
patient reported